Cargando…

Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome

This is a unique case of ectopic adrenocorticotropic hormone (ACTH)-secreting mediastinal neuroendocrine tumor, presumably thymic in origin, with suspected lung metastasis in a 61-year-old man who was successfully managed with long-term metyrapone alone. He presented with severe hypokalemia and hype...

Descripción completa

Detalles Bibliográficos
Autor principal: Wong, Tin Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578376/
https://www.ncbi.nlm.nih.gov/pubmed/37908265
http://dx.doi.org/10.1210/jcemcr/luac008
_version_ 1785121506566602752
author Wong, Tin Wai
author_facet Wong, Tin Wai
author_sort Wong, Tin Wai
collection PubMed
description This is a unique case of ectopic adrenocorticotropic hormone (ACTH)-secreting mediastinal neuroendocrine tumor, presumably thymic in origin, with suspected lung metastasis in a 61-year-old man who was successfully managed with long-term metyrapone alone. He presented with severe hypokalemia and hypertension, complicated with psychosis and vertebral collapse. He survived through a complicated course of pulseless ventricular tachycardia arrest and a severe Cushing storm due to drug nonadherence. For 3 years since diagnosis, he remained stable on metyrapone, and was able to achieve biochemical eucortisolism, with normalization of ACTH and cortisol levels. In addition, his tumor was reduced in size and the suspicious lung metastasis regressed.
format Online
Article
Text
id pubmed-10578376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105783762023-10-31 Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome Wong, Tin Wai JCEM Case Rep Case Report This is a unique case of ectopic adrenocorticotropic hormone (ACTH)-secreting mediastinal neuroendocrine tumor, presumably thymic in origin, with suspected lung metastasis in a 61-year-old man who was successfully managed with long-term metyrapone alone. He presented with severe hypokalemia and hypertension, complicated with psychosis and vertebral collapse. He survived through a complicated course of pulseless ventricular tachycardia arrest and a severe Cushing storm due to drug nonadherence. For 3 years since diagnosis, he remained stable on metyrapone, and was able to achieve biochemical eucortisolism, with normalization of ACTH and cortisol levels. In addition, his tumor was reduced in size and the suspicious lung metastasis regressed. Oxford University Press 2022-11-29 /pmc/articles/PMC10578376/ /pubmed/37908265 http://dx.doi.org/10.1210/jcemcr/luac008 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Wong, Tin Wai
Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title_full Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title_fullStr Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title_full_unstemmed Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title_short Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
title_sort long-term treatment with metyrapone in a man with ectopic cushing syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578376/
https://www.ncbi.nlm.nih.gov/pubmed/37908265
http://dx.doi.org/10.1210/jcemcr/luac008
work_keys_str_mv AT wongtinwai longtermtreatmentwithmetyraponeinamanwithectopiccushingsyndrome